Walvax Biotechnology Co., Ltd. (SHE:300142)
China · Delayed Price · Currency is CNY 13.13
-0.01 (-0.08%)
Aug 10, 2026, 3:04 PM CST
Walvax Biotechnology Market Cap
Walvax Biotechnology has a market cap or net worth of 21.02 billion as of August 10, 2026. Its market cap has increased by 0.92% in one year.
Market Cap
21.02B
Enterprise Value
21.81B
Revenue
2.40B
Ranking
n/a
PE Ratio
74.05
Stock Price
13.13
ChartMarket Cap Chart
Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 21.02B, an increase of 54.13%. That is a compound annual growth rate of 2.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 21.02B | 20.44% |
| Dec 31, 2025 | 17.45B | -9.69% |
| Dec 31, 2024 | 19.32B | -48.62% |
| Dec 29, 2023 | 37.60B | -41.50% |
| Dec 30, 2022 | 64.27B | -28.12% |
| Dec 31, 2021 | 89.42B | 50.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tasly Pharmaceutical Group | 23.14B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 21.77B |
| Jilin Aodong Pharmaceutical Group | 21.26B |
| Chengdu Kanghong Pharmaceutical Group | 20.96B |
| Hybio Pharmaceutical | 19.86B |
| Kangmei Pharmaceutical | 18.53B |
| Joincare Pharmaceutical Group Industry | 18.31B |
| Harbin Pharmaceutical Group | 17.23B |